Advertisement

Topics

Breast cancer: T-DM1 — an important agent in the history of breast cancer management

07:18 EDT 9 Aug 2017 | Nature Publishing

Updated results from the EMILIA and TH3RESA trials in patients with advanced-stage HER2-positive breast cancer confirm the overall survival benefit and favourable safety profile of T-DM1 after prolonged follow-up durations. The efficacy of T-DM1 as a second or later line of treatment indicates that HER2 is a relevant therapeutic target throughout the course of the disease.

Original Article: Breast cancer: T-DM1 — an important agent in the history of breast cancer management

NEXT ARTICLE

More From BioPortfolio on "Breast cancer: T-DM1 — an important agent in the history of breast cancer management"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...